Yong Zhang

Yong Zhang

Auto-generated profile, based on publicly available information

Yong Zhang

The Third Affiliated Hospital of Sun Yat-sen University

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
XLXiao-Dan Liu
Xiao-Dan Liu
RFRui-Fang Fan
Rui-Fang Fan
YZYong Zhang
Yong Zhang
HYHongzhi Yang
Hongzhi Yang
ZFZhi-Gang Fang
Zhi-Gang Fang
JLJia-Jun Liu
Jia-Jun Liu
Tanshinone I (Tan-I) is a diterpene quinone extracted from the traditional herbal medicine Salvia miltiorrhiza Bunge . Recently, Tan-I has been reported to have anti-tumor effects. In this study, we investigated the growth inhibition and apoptosis inducing effects of Tan-I on three kinds of monocytic leukemia cells (U937, THP-1 and SHI 1). Cell viability was measured by MTT assay. Cell apoptosis was assessed by flow cytometry (FCM) and AnnexinV/PI staining. Reverse transcriptase polymerase chain reaction (RT-PCR) and PCR–enzyme-linked immunosorbent assay (ELISA) were used to detect human telomerase reverse transcriptase (hTERT) expression and telomerase activity before and after apoptosis.The activity of caspase-3 was determined by Caspase colorimetric assay kit and Western blot analysis. Expression of the anti-apoptotic gene Survivin was assayed by Western blot and Real-time RT-PCR using the ABI PRISM 7500 Sequence Detection System. The resultsrevealed that Tan-I could inhibit the growth of these three kinds of leukemia cells and cause apoptosis in a time- and dose-dependent manner. After treatment by Tan-I for 48 h, Western blotting showed cleavage of the caspase-3 zymogen protein with the appearance of its 17-kD subunit, and a 89-kD cleavage product of poly (ADP-ribose) polymerase (PARP), a known substrate of caspase-3, was also found clearly. The expression of hTERT mRNA as well as activity of telomerase were decreased concurrently in a dose-dependent manner. Moreover, Real-time RT-PCR and Western blot revealed a significant down-regulation of Survivin. We therefore conclude that the induction of apoptosis by Tan-I in monocytic leukemia U937 THP-1 and SHI 1 cells is highly correlated with activation of caspase-3 and decreasing of hTERT mRNA expression and telomerase activity as well as down-regulation of Survivin expression. To our knowledge, this is the first report about the effects of Tan-I on monocytic leukemia cells.

12 August 2011 in Cell Biochemistry and Biophysics
Verified
Journal Article
Closed access
PDF file
JLJia jun Liu
Jia jun Liu
XDXue-Jun Dai
Xue-Jun Dai
YXYan Xu
Yan Xu
PLPei-Qing Liu
Pei-Qing Liu
YZYong Zhang
Yong Zhang
HHHe-Qing Huang
He-Qing Huang

Verified
Journal Article
Open access
PDF file
JLJia-Jun Liu
Jia-Jun Liu
YZYong Zhang
Yong Zhang
WGWei-Bin Guang
Wei-Bin Guang
HYHongzhi Yang
Hongzhi Yang
DLDong-Jun Lin
Dong-Jun Lin
RXRuo-Zhi Xiao
Ruo-Zhi Xiao
In this study two monocytic leukemia cell lines, U937 and THP-1 cells, were used to investigate the anti-proliferation effects caused by ponicidin. Cell viability was measured by an MTT assay. Cell apoptosis was assessed by flow cytometry as well as DNA fragmentation analysis. Cell morphology was observed using an inverted microscope and Hoechst 33258 staining. RT-PCR and Western blot analysis were used to detect survivin as well as Bax and Bcl-2 expressions after the cells were treated with different concentrations of ponicidin. The results revealed that ponicidin could inhibit the growth of U937 and THP-1 cells significantly by induction of apoptosis. The suppression was in both time- and dose-dependent manner. Marked morphological changes of cell apoptosis were observed clearly after the cells were treated with ponicidin for 48~72 h. RT-PCR and Western blot analysis demonstrated that both survivin and Bcl-2 expressions were down-regulated remarkably while Bax expression remained constant before and after apoptosis occurred. We therefore conclude that ponicidin has significant anti-proliferation effects by inducing apoptosis on leukemia cells in vitro, downregulation of survivin as well as Bcl-2 expressions may be the important apoptosis inducing mechanisms. The results suggest that ponicidin may serve as potential therapeutic agent for leukemia.

1 May 2009 in Laboratory Medicine
Verified
Journal Article
Open access
PDF file
JLJia-Jun Liu
Jia-Jun Liu
YXYan- Xu
Yan- Xu
YZYong Zhang
Yong Zhang
RXRuo-Zhi Xiao
Ruo-Zhi Xiao
DLDong-Jun Lin
Dong-Jun Lin
Objective. To investigate the apoptotic effects of peroxisome proliferator-activated receptor γ (PPAR-γ) agonist rosiglitazone (RGZ) on leukemia HL-60

1 November 2008 in Chinese Medical Journal
Verified
Journal Article
Closed access
YZYong Zhang
Yong Zhang
YMYi Ma
Yi Ma
HLHan-Ping Lu
Han-Ping Lu
JGJin-Hui Gao
Jin-Hui Gao
CLChang-Sheng Liang
Chang-Sheng Liang
HWHua-Qiao Wang
Hua-Qiao Wang
Background The failure of hormone treatment for advanced prostate cancer might be related to aberrant activation of the androgen receptor. We have shown that 125I labeled triple-helix forming oligonucleotide (TFO) against the androgen receptor gene inhibits androgen receptor expression and cell proliferation of LNCaP prostate cancer cells in vitro. This study aimed at exploring the effects of the 125I-TFO on prostate tumor growth in vivo using a nude mouse xenograft model. Methods TFO was labeled with 125I by the iodogen method. Thirty-two nude mice bearing LNCaP xenograft tumors were randomized into 4 groups and were intratumorally injected with 125I-TFO, unlabeled TFO, Na125I and normal saline. Tumor size was measured weekly. The tumor growth inhibition rate (RI) was calculated by measurement of tumor weight. The expression of the androgen receptor gene was performed by RT-PCR and immunohistochemical study. The prostate specific antigen (PSA) serum levels were measured by enzyme linked immunosorbent assay. The tumor cell apoptosis index (AI) was detected by TUNEL assay. Results Tumor measurements showed that tumor development was significantly inhibited by either 125I-TFO or TFO, with tumor RIs of 50.79% and 32.80% respectively. 125I-TFO caused greater inhibition of androgen receptor expression and higher AIs in tumor tissue than TFO. Both the tumor weight and the PSA serum levels in 125I-TFO treated mice ((0.93±0.15) g and (17.43±1.85) ng/ml, respectively) were significantly lower than those ((1.27±0.21) g and (28.25±3.41) ng/ml, respectively) in TFO treated mice (all P <0.05). Na125I did not significantly affect tumor growth and androgen receptor expression in tumor tissue. Conclusions The 125I-TFO can effectively inhibit androgen receptor expression and tumor growth of human prostate cancer xenografts in vivo. The inhibitory efficacy of 125I-TFO is more potent than that of TFO, providing a reference for future studies of antigen radiotherapy.